Increasing the plasma half-life of trichosanthin by coupling to dextran.
Trichosanthin (TCS) is a plant protein which has a wide spectrum of pharmacological activities. It was demonstrated recently that this compound suppressed the replication of human immunodeficiency virus (HIV-1) in vitro. The mechanism of action is believed to be inhibition of protein synthesis. Trichosanthin is a low molecular weight protein which is expected to be easily filtered and eliminated through the kidney. To minimize renal loss, the molecular size of trichosanthin can be increased by coupling to dextran. The larger complex will not undergo glomerular filtration and therefore renal loss can be prevented. This study investigates the kidney's role in trichosanthin elimination and the beneficial effect afforded by coupling to dextran in prolonging plasma half-life. For this purpose, a radioimmunoassay has been developed to determine the concentration of TCS in plasma and urine. The sensitivity of this assay is in the nanogram range. Trichosanthin was coupled to dextran T40 by a dialdehyde method and successful coupling was confirmed by gel filtration chromatography. The complex retained specific binding to trichosanthin antibodies with decreased affinity which can be partially reversed after incubation with dextranase; an enzyme that digested dextran. The pharmacokinetics of intravenously administered trichosanthin (0.75 mg/kg) was compared between two groups of rats with normal and impaired renal function (bilateral renal arterial ligation). Rats with ligation showed a decrease in plasma clearance from 4780 +/- 570 to 220 +/- 20 microL/min and an increase in the mean residence time from 9 +/- 1 to 145 +/- 16 min. Despite the several-fold difference in these parameters, recovery of trichosanthin from normal rat urine was only 0.38 +/- 0.05%. This value can be increased by using higher injection doses. The data indicate that the kidney is an important organ for the elimination of trichosanthin. When the dextran-trichosanthin complex was injected into normal rats trichosanthin activity was not detected in the urine. All the pharmacokinetic parameters suggest that the dextran-trichosanthin complex stayed longer in the body and maintained a much higher plasma concentration than trichosanthin.
Ko
W H
WH
Department of Physiology, Chinese University of Hong Kong, Shatin.
Wong
C C
CC
Yeung
H W
HW
Yung
M H
MH
Shaw
P C
PC
Tam
S C
SC
D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D003910:Dextranase / Q000494:pharmacology; D003911:Dextrans / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D006207:Half-Life; D007668:Kidney / Q000378:metabolism*; D011863:Radioimmunoassay; D051381:Rats; D015978:Trichosanthin / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine
D003911:Dextrans; D015978:Trichosanthin; D003910:Dextranase